Rusan Pharma launches Parkinson’s Disease drug

New Delhi: Drug maker Rusan Pharma Thursday said it has launched a drug to treat Parkinson’s disease. The drug — Aposan — is used to treat motor fluctuations in patients with Parkinson’s Disease which are not sufficiently controlled by oral medications currently available in the country.

The company said it has developed the drug, which would be available in the form of injections, pen and continuous infusion pumps, indigenously and has received approval from the Drug Controller General of India (DCGI).

“The company has always put forward indigenously developed high technology advanced delivery products in the Indian market,” Rusan Pharma MD Kunal Saxena said in a statement.

The company wants to ensure that the treatment is affordable and accessible to all Parkinson’s disease patients, he added.

  • Related Posts

    Civil society group SAM calls for greater transparency involving clinical trials

    The group had approached the Supreme Court, raising concerns on clinical trials in a Public Interest Litigation in 2012 Civil society group Swasthya Adhikar Manch (SAM) has called for greater…

    Different packaging, typos expose fake Mounjaro racket

    Gurugram: Colour dissimilarity to typographical errors… conspicuous differences in the packaging of counterfeit Mounjaro injections led the Drugs Control Office to crack down on the illicit sale and production of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Civil society group SAM calls for greater transparency involving clinical trials

    Civil society group SAM calls for greater transparency involving clinical trials

    Different packaging, typos expose fake Mounjaro racket

    Different packaging, typos expose fake Mounjaro racket

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    To Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this Book

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection